Mass. movers

Cerulean drug shows antitumor potential

The Cerulean drug is used to treat ovarian cancer.

Associated Press/File 2014

The Cerulean drug is used to treat ovarian cancer.


Cerulean Pharma Inc., of Cambridge, announced that its CRLX101, a proprietary investigational drug, exhibits powerful antitumor properties, according to preclinical data. The drug was potent alone as well as in combination with Avastin, a Genentech Inc. cancer drug. “The combination of CRLX101 and Avastin is synergistic, with the potential to enhance survival of patients with ovarian cancer,” said Robert S. Kerbel, a researcher on the manuscript of data released Tuesday.

Loading comments...
Real journalists. Real journalism. Subscribe to The Boston Globe today.
You're reading  1 of 5 free articles.
Get UNLIMITED access for only 99¢ per week Subscribe Now >
You're reading1 of 5 free articles.Keep scrolling to see more articles recomended for you Subscribe now
We hope you've enjoyed your 5 free articles.
Continue reading by subscribing to for just 99¢.
 Already a member? Log in Home
Subscriber Log In

We hope you've enjoyed your 5 free articles'

Stay informed with unlimited access to Boston’s trusted news source.

  • High-quality journalism from the region’s largest newsroom
  • Convenient access across all of your devices
  • Today’s Headlines daily newsletter
  • Subscriber-only access to exclusive offers, events, contests, eBooks, and more
  • Less than 25¢ a week
Marketing image of
Marketing image of